Abbott Piotroski F Score


USD 110.79  1.24  1.11%   

This module uses fundamental data of Abbott Laboratories to approximate its Piotroski F score. Abbott Laboratories F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Abbott Laboratories. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Abbott Laboratories financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please continue to Abbott Laboratories Altman Z Score, Abbott Laboratories Correlation, Abbott Laboratories Valuation, as well as analyze Abbott Laboratories Alpha and Beta and Abbott Laboratories Hype Analysis.
Abbott Laboratories Total Debt is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Total Debt of 18.05 Billion in 2021. Debt Current is likely to gain to about 773.8 M in 2022, whereas Debt to Equity Ratio is likely to drop 1.07 in 2022. Abbott Laboratories Dividend Yield is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Dividend Yield of 0.0117 in 2021. Earnings per Basic Share is likely to gain to 4.28 in 2022, whereas Accrued Expenses Turnover is likely to drop 5.11 in 2022.
At this time, it appears that Abbott Laboratories' Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
Piotroski F Score - Poor
Current Return On AssetsPositiveFocus
Change in Return on AssetsDecreasedFocus
Cash Flow Return on AssetsPositiveFocus
Current Quality of Earnings (accrual)ImprovingFocus
Asset Turnover GrowthDecreaseFocus
Current Ratio ChangeDecreaseFocus
Long Term Debt Over Assets ChangeHigher LeverageFocus
Change In Outstending SharesIncreaseFocus
Change in Gross MarginIncreaseFocus

Abbott Laboratories Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Abbott Laboratories is to make sure Abbott is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Abbott Laboratories' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Abbott Laboratories' financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares1.9 B1.8 B
Notably Up
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B
Notably Up
Slightly volatile
Net Cash Flow from Operations9.1 B10.5 B
Fairly Down
Total Assets74.6 B75.2 B
Slightly Down
Slightly volatile
Total Liabilities39.7 B39.2 B
Fairly Up
Slightly volatile
Current Assets21.3 B24.2 B
Fairly Down
Current Liabilities11.4 B13.1 B
Fairly Down
Slightly volatile
Total Debt19.2 B18.1 B
Notably Up
Slightly volatile
Return on Average Assets0.07650.096
Significantly Down
Gross Margin0.630.57
Significantly Up
Slightly volatile
Asset Turnover0.570.584
Fairly Down
Slightly volatile

Abbott Laboratories F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Abbott Laboratories' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Abbott Laboratories in a much-optimized way.

About Abbott Laboratories Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Weighted Average Shares

1.88 Billion

Abbott Laboratories Weighted Average Shares is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Weighted Average Shares of 1.77 Billion in 2021

Abbott Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbott Laboratories from analyzing Abbott Laboratories' financial statements. These drivers represent accounts that assess Abbott Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbott Laboratories' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee4.82 K22.99 K34.46 K41.13 K62.58 K56.09 K
Revenue Per Employee276.67 K296.87 K298.17 K316.64 K381.19 K391.53 K
Average Assets72.63 B69.53 B68.12 B69.29 B73.76 B72.94 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA6.28 B7.01 B7.76 B8.87 B12.28 B10.6 B
Earnings Before Interest Taxes and Depreciation Amortization USD6.28 B7.01 B7.76 B8.87 B12.28 B10.6 B
Earnings before Tax2.35 B2.91 B4.08 B4.99 B8.21 B6.71 B
Average Equity31.66 B31 B31.59 B31.46 B34.62 B34.04 B
Enterprise Value112.35 B143.22 B168.61 B208.14 B257.96 B207.34 B
Free Cash Flow4.43 B4.91 B4.5 B5.72 B8.65 B7.28 B
Invested Capital40.16 B31.45 B30.8 B33.71 B34.37 B35.08 B
Invested Capital Average38.38 B32.91 B32.55 B33.39 B33.57 B33.94 B
Market Capitalization99.34 B127.04 B153.61 B194.06 B248.87 B197.54 B
Tangible Asset Value30.76 B24.98 B27.67 B34.02 B39.23 B34.16 B
Working Capital11.23 B5.62 B4.8 B8.53 B11.13 B9.9 B

Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.

Abbott Laboratories Investors Sentiment

The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbott Laboratories.

Abbott Laboratories Implied Volatility

Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abbott Laboratories Altman Z Score, Abbott Laboratories Correlation, Abbott Laboratories Valuation, as well as analyze Abbott Laboratories Alpha and Beta and Abbott Laboratories Hype Analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
196 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.